AOP-HEALTH-GROUP
Fondazione per la Ricerca dell'Ospedale di Bergamo (FROM) announced the publication of the latest results from the LOW-PV trial in the NEJM Evidence.
The findings support a paradigm shift in the treatment of patients with Polycythaemia Vera, a rare kind of blood cancer. AOP Orphan Pharmaceuticals GmbH (AOP Health) congratulates Prof. Tiziano Barbui and his team on this success and is pleased to have contributed to FROM’s important work as a reliable research partner.
Find out more about the trial and its results here.
About AOP Health
The AOP Health Group incorporates several companies including AOP Orphan Pharmaceuticals GmbH with its seat in Vienna, Austria (“AOP Health”). The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions operating from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. The claim “Needs. Science. Trust.” sums up the foundation of the Group’s success: establishing trust through a continually high level of investment in research and development and a highly consistent and pragmatic orientation towards the needs of all stakeholders – especially the patients and their families as well as the healthcare professionals treating them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005571/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AMRA-MEDICAL25.4.2024 13:51:35 CEST | Press release
Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study
MA-NETSCOUT-SYSTEMS25.4.2024 12:06:33 CEST | Press release
Geopolitical Unrest Generates an Onslaught of DDoS Attacks, According to the Latest NETSCOUT Threat Intelligence Report
HANSEN-TECHNOLOGIES25.4.2024 12:01:33 CEST | Press release
Stockholm Exergi Selects Hansen to Automate and Optimise Power Trading Operations
BUREAU-VERITAS25.4.2024 09:21:31 CEST | Press release
Bureau Veritas: Strong Start to the Year; 2024 Outlook Confirmed
TXONE-NETWORKS25.4.2024 09:05:30 CEST | Press release
New CPS Protection Platform: TXOne Networks Presents SageOne in Hannover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom